Trouble falling or staying asleep is linked to 87% greater odds of death from any cause over the next nine years in people with diabetes, a new study finds. A simple question can help clinicians identify patients who may need additional support to lower their risk, investigators say.
Reinvigorating the use of first-line therapies such as statins, metformin, ACE inhibitors or ARB is key to getting care and outcomes back on track, investigators say.
Twist in the FDA’s Alzheimer’s decision: no limits on which patients can get the drug … Biden administration advises changes to policies linked to N95 shortages … Frailty tied to increased mortality in COVID: A living review and meta-analysis … In type 1 diabetes, blood sugar extremes are tied to sixfold risk of dementia … Exercise likely to be best treatment for depression in coronary heart disease … “Immunological memory” protects against COVID re-infection for at least 11 months, analysis shows
Prediabetes may be more destructive to the heart and vascular system than many clinicians realize, nearly doubling the risk of adverse events, according a new study to be presented at next week’s ACC conference.
Farxiga, an SGLT2 inhibitor, was found to reduce the risk of worsening renal function or cardiovascular or renal death by 39% in patients with chronic kidney disease — with and without type 2 diabetes.
Some cases of type 1 and type 2 diabetes are occurring in COVID-19 patients who have no known risk factors or prior health concerns, according to a report.
Short-term use of NSAIDs, which include ibuprofen, aspirin and naproxen, is linked to kidney damage and high potassium levels, researchers have found.
Glucagon to treat severe hypoglycemia is available in a generic formula for the first time in 20 years.
People who go to bed late and get up late exercise 56% less than their early bird counterparts, a new study finds. A shift in sleep habits could change their health prognoses for the better, investigators say.
New studies show evidence that common glucose-lowering drugs significantly lower the rate of kidney decline and death.
